"L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent" Journal of Geriatric Psychiatry and Neurology
Movement Disorders: Official Journal of the Movement Disorder Society Schwarz, ST; Afzal, M; Morgan, PS; Bajaj, N; Gowland, PA; Auer, DP 2014

Oxford Handbook of Clinical Medicine.

15
مرض باركنسون: الأسباب، الأعراض والعلاج
"The clinical symptoms of Parkinson's disease"
مرض باركنسون
"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis"
مرض الباركنسون : ما هي الأسباب و ما هو العلاج
; Chan, Piu; Dubois, Bruno; Gasser, Thomas; Goetz, Christopher G
Orally inhaled levodopa CVT-301 for early morning OFF periods in Parkinson's disease 20 Suppl 1 : S221—38
"Symptomatic pharmacological therapy in Parkinson's disease" "The differential diagnosis of Parkinson's disease"

"Parkinson's disease: from monogenic forms to genetic susceptibility factors".

27
مرض باركنسون
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators
أسباب و أعراض مرض الباركنسون و المضاعفات الناتجة عنه
"rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets"
ما هو مرض باركنسون
"Major nutritional issues in the management of Parkinson's disease"